Pharsight

Drugs that contain Telmisartan

1. Micardis patents expiration

MICARDIS's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8003679 BOEHRINGER INGELHEIM Use of inhibitors of the renin-angiotensin system
Oct, 2022

(1 year, 1 month ago)

Market Authorisation Date: 10 November, 1998

Treatment: Treatment or prevention of stroke

Dosage: TABLET;ORAL

How can I launch a generic of MICARDIS before it's drug patent expiration?
More Information on Dosage

MICARDIS family patents

Family Patents